Skip to search formSkip to main content

Chronic Myelomonocytic Leukemia in Remission

Known as: CMML in Remission, Chronic Myelomonocytic Leukaemia (in Remission) 
Chronic myelomonocytic leukemia not growing; responding to treatment.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
BACKGROUND Molecular genetic abnormalities are observed in over 90% of chronic myelomonocytic leukemia (CMML) cases. Recently… Expand
  • table 1
  • table 3
  • table 2
  • figure 1
  • table 4
Is this relevant?
2018
2018
Bone marrow stromal cells (BMSCs) represent an important cellular component of the bone marrow microenvironment, which play an… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2018
2018
To the Editor, We thank the author for her comment and appreciate her concerns on the need for uniformity with regards to the… Expand
Is this relevant?
Review
2016
Review
2016
Itonaga et al. extensively evaluated the impact of Graft Versus ost Disease (GVHD) on the outcome of a large cohort of 141… Expand
Is this relevant?
2013
2013
We sought to describe the clinical features and outcomes of therapy-related chronic myelomonocytic leukemia (t-CMML) and compare… Expand
  • table 1
Is this relevant?
1998
1998
BACKGROUND The use of chemotherapy in juvenile chronic myelomonocytic leukemia (J-CMML) has not generally been successful. Our… Expand
Is this relevant?
Review
1990
Review
1990
Exposure to genotoxic agents such as insecticides, pesticides, and solvents correlated with abnormal karyotypes and development… Expand
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?